Publicacions en col·laboració amb investigadors/es de Baylor University Medical Center (15)

2023

  1. Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy

    Neurology and Therapy, Vol. 12, Núm. 5, pp. 1759-1775

2017

  1. Secukinumab demonstrates greater sustained improvements in daily activities and personal relationships than ustekinumab in patients with moderate-to-severe plaque psoriasis: 52-week results from the CLEAR study

    Journal of the European Academy of Dermatology and Venereology, Vol. 31, Núm. 10, pp. 1693-1699

2011

  1. Erratum: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: A consensus statement (Annals of Surgical Oncology 14 (128-133)DOI: 10.1245/s10434-006-9185-7)

    Annals of Surgical Oncology

2010

  1. Identifying predictors of central nervous system disease in solid organ transplant recipientswith cryptococcosis

    Transplantation, Vol. 89, Núm. 1, pp. 69-74

  2. Unrecognized pretransplant and donor-derived cryptococcal disease in organ transplant recipients

    Clinical Infectious Diseases, Vol. 51, Núm. 9, pp. 1062-1069

2009

  1. Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis

    Clinical Infectious Diseases, Vol. 49, Núm. 11, pp. 1721-1728

2008

  1. Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: Correlation with outcome in solid organ transplant recipients with cryptococcosis

    Antimicrobial Agents and Chemotherapy, Vol. 52, Núm. 2, pp. 735-738

  2. Central nervous system cryptococcosis in solid organ transplant recipients: Clinical relevance of abnormal neuroimaging findings

    Transplantation, Vol. 86, Núm. 5, pp. 647-651

  3. Pulmonary cryptococcosis in solid organ transplant recipients: Clinical relevance of serum cryptococcal antigen

    Clinical Infectious Diseases, Vol. 46, Núm. 2

2007

  1. Cryptococcus neoformans in organ transplant recipients: Impact of calcineurin-inhibitor agents on mortality

    Journal of Infectious Diseases, Vol. 195, Núm. 5, pp. 756-764

  2. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: A consensus statement

    Annals of Surgical Oncology, Vol. 14, Núm. 1, pp. 128-133

2006

  1. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplantation recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus

    Liver Transplantation, Vol. 12, Núm. 10, pp. 1464-1472

2005

  1. Allograft loss in renal transplant recipients with Cryptococcus neoformans associated immune reconstitution syndrome

    Transplantation, Vol. 80, Núm. 8, pp. 1131-1133

  2. An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients

    Clinical Infectious Diseases, Vol. 40, Núm. 12, pp. 1756-1761

  3. Antifungal management practices and evolution of infection in organ transplant recipients with Cryptococcus neoformans infection

    Transplantation, Vol. 80, Núm. 8, pp. 1033-1039